ZILVER VASCULAR STENT
Cook Ireland, Ltd. · Decision date Jun 26, 2006
What did the FDA approve?
The FDA approved the Zilver Vascular Stent from Cook Ireland, Ltd. on June 26, 2006, under PMA number P050017. The dated approval statement describes the device as indicated for use as an adjunct to percutaneous transluminal angioplasty (PTA) in treating symptomatic vascular disease of the iliac arteries up to 100 mm in length, with a reference vessel diameter of 5 to 9 mm.
The statement specifies that patients must be suitable for PTA and stent treatment. The device is categorized as an iliac stent under product code NIO in the cardiovascular specialty. No documents, supplement type, or supplement reason are attached to this record, so the approval scope is limited to the original PMA as described in the dated statement.
FDA approval order statement
APPROVAL FOR THE ZILVER VASCULAR STENT. THIS DEVICE IS INDICATED FOR USE AS AN ADJUNCT TO PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) IN THE TREATMENT OF SYMPTOMATIC VASCULAR DISEASE OF THE ILIAC ARTERIES UP TO 100 MM IN LENGTH, WITH A REFERENCE VESSEL DIAMETER OF 5 TO 9 MM. PATIENTS MUST BE SUITABLE FOR PTA AND STENT TREATMENT.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Cardiovascular
- Decision date
- Jun 26, 2006
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P050017
- Regulatory pathway
- Premarket approval application
- Applicant
- Cook Ireland, Ltd.
- Product code
- NIO
- Decision code
- APPR
- Decision date
- Jun 26, 2006
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: STENT, ILIAC.
- Applicant
- Cook Ireland, Ltd.
- Product code
- NIO
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P050017 received
Application receipt date recorded by FDA.
P050017 · FDA decision
APPR
P050017/S027 · Related supplement
Zilver 635 Vascular Stent, Zilver 518 Vascular Stent
Timeline entries are records held by MedtechLedger for P050017. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P050017
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Cook Ireland, Ltd. | PMA supplement | Nov 6, 2026 | FDA |
Explore the linked device profile
Other records with product code NIO
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Medtronic Vascular, Inc. | PMA supplement | Oct 16, 2026 | FDA | |
S.M.A.R.T. CONTROL Nitinol Stent SystemP020036/S061 | Cordis US Corporation | PMA supplement | Oct 15, 2026 | FDA |
| Biotronik AG | PMA supplement | Sep 11, 2026 | FDA | |
| Biotronik AG | PMA approval | Dec 17, 2015 | FDA | |
INTRASTENT DOUBLESTRUT STENTP030045 | Medtronic Vascular, Inc. | PMA approval | Jun 8, 2004 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Cook Ireland, Ltd.
- Headquarters
- Not reported
- Brand website
- cookmedical.com
- FDA applicant address
- O' Halloran Rd., National Technology Park, Limerick
Sources and methodology
- Original FDA record: P050017
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



